Fentanyl Citrate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

33 Suppliers, 14 USDMF, 12 CEP/COS, 3 JDMF, 4 EU WC, 4 KDMF, 16 NDC API, 17 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

DOSSIERs // Finished Dosage Forms

186 Dossiers, 77 FDA Orange Book, 68 Europe, 14 Canada, 3 South Africa, 24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE, TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 18 Roquette, 17 SPI Pharma, 17 Kerry, 11 Microlex e.U, 10 Corel Pharma Chem, 10 Sigachi Industries, 10 Gangwal Healthcare, 8 Seppic, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Actylis, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 DFE Pharma, 4 Prachin Chemical, 4 Vasa Pharmachem, 4 BASF, 3 Kima Chemical, 2 DKSH, 2 Pfanstiehl, 2 The Dow Chemical Company, 2 Pharmatrans-Sanaq, 2 Rochem International Inc, 1 Finar, 1 Huzhou Sunflower Pharmaceutical, 1 Alcedo Pharmachem, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Jai Radhe Sales, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Qualicaps, 1 Boai NKY Pharmaceuticals Ltd

EXCIPIENTS BY APPLICATIONS

57 Fillers, Diluents & Binders, 43 Coating Systems & Additives, 30 Direct Compression, 28 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 18 Taste Masking, 17 Thickeners and Stabilizers, 16 Granulation, 15 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 7 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Solubilizers, 3 Rheology Modifiers, 2 Coloring Agents, 2 Emulsifying Agents, 2 Topical

GLOBAL SALES INFORMATION

42 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

11 APIs, 5 DOSSIERS // FDF

PATENTS

36 US Patents, 17 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

35 News

35 News

US Medicaid Prescriptions
Finished Drug Prices

Filters

FILTER :

filter Applicant

All (12)

01 PAR PHARM (6)

02 SPECGX LLC (6)

filter Active Ingredients

All (12)

01 FENTANYL CITRATE (12)

filter Country

All (12)

01 USA (12)

filter Dosage Form Route

All (12)

01 TROCHE/LOZENGE;TRANSMUCOSAL (12)

PAR PHARM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.2MG BASE

Price

9.7993

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

PAR PHARM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.4MG BASE

Price

9.7993

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

PAR PHARM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.6MG BASE

Price

9.7993

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

PAR PHARM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.8MG BASE

Price

9.7993

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

PAR PHARM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 1.2MG BASE

Price

9.7993

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

PAR PHARM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 1.6MG BASE

Price

9.7993

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

SPECGX LLC

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Ireland

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.2MG BASE

Price

10.7827

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

SPECGX LLC

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Ireland

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.4MG BASE

Price

10.7827

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

SPECGX LLC

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Ireland

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.6MG BASE

Price

10.7827

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

SPECGX LLC

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Ireland

Virtual Booth

Digital Content

Fentanyl Citrate

PDF Supplier PDF

URL Supplier Web Content

Proprietary Name

FENTANYL CITRATE

Dosage Form Route

TROCHE/LOZENGE;TRANSMUCOSAL

Strength

EQ 0.8MG BASE

Price

10.7827

Price Per Pack

Currency

RX/OTC/DISCN

DISCN

Approval Date

2009-10-30

Country

USA

ASK
US

Upload
your Marketing & Sales content

Pharmacy pricing data of Fentanyl Citrate obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Fentanyl Citrate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

33 Suppliers

14 USDMF

12 CEP/COS

3 JDMF

4 EU WC

4 KDMF

16 NDC API

17 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

DOSSIERs // Finished Dosage Forms

186 Dossiers

77 FDA Orange Book

68 Europe

14 Canada

3 South Africa

24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE

TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE

TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

18 Roquette

17 SPI Pharma

17 Kerry

11 Microlex e.U

10 Corel Pharma Chem

10 Sigachi Industries

10 Gangwal Healthcare

8 Seppic

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Actylis

6 Lonza Capsugel

5 Ingredion Pharma Solutions

5 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 DFE Pharma

4 Prachin Chemical

4 Vasa Pharmachem

4 BASF

3 Kima Chemical

2 DKSH

2 Pfanstiehl

2 The Dow Chemical Company

2 Pharmatrans-Sanaq

2 Rochem International Inc

1 Finar

1 Huzhou Sunflower Pharmaceutical

1 Alcedo Pharmachem

1 Nanjing Well Pharmaceutical

1 ACG Worldwide

1 Jai Radhe Sales

TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;SUBLINGUAL - EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons